This article explores the rise of biotech collaborations in pharma, the impact of M&A on the industry, the role of technology in biotech advancements, the regulatory challenges faced by pharma in its ...
Read moreTo this day, more than 7,000 groups of genes can be traced back to the last common ancestor of bilaterians, according to a study of 20 different bilaterian species including humans, sharks, mayflies, ...
Read moreHan creado un imán duro de espesor atómico por primera vez a nivel mundial. Se trata del imán más fino que existe y que podrá existir nunca, con una dirección magnética definida, de temperatura...
Read moreUna nueva guía de la UPV/EHU detalla los azúcares y edulcorantes utilizados en la Unión Europea y sus posibles efectos sobre la salud
Read morePivotal is collaborating with the Alliance for Child Vaccination and Gavi in the fight against children’s mortality in the world’s poorest countries.
Read moreIt has been identified how the combination of inhibitors of PP2A and WEE1 proteins induces the death of colon cancer cells, offering a new perspective in the treatment of this disease.
Read moreThe new regimen has the same efficacy as the standard regimen, but only a quarter of the duration, which reduces the percentage of dropouts and side effects.
Read moreThe study demonstrates that a specific genetic mutation (C122Y) in the Kir2.1 potassium channel alters the function not only of Kir2.1 but also of the main cardiac sodium channel NaV1.5, thus establis...
Read moreLaura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...
Read moreHan comprobado que este biomaterial inyectable, diseñado mediante bioingeniería, puede sellar y rellenar perforaciones en córneas inflamadas y promover su regeneración, evitando así la necesidad ...
Read moreDescriben RMC-7977, un compuesto preclínico con un perfil inhibidor multiselectivo de RAS(ON), que fue diseñado para inhibir el espectro completo de mutaciones oncogénicas de RAS, incluyendo mutaci...
Read moreEl proyecto tiene como objetivo establecer la terapia óptima para dos formas comunes de cáncer de la sangre: la leucemia mieloide aguda (AML) y la leucemia linfocítica crónica (CLL). Liderado por ...
Read more